◆英語タイトル:Quantum Genomics SA (ALQGC) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH136539FSA
◆発行会社(調査会社):
GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
Quantum Genomics SA (Quantum Genomics) is a bio pharmaceutical company which develops novel medicines in the field of cardiovascular diseases. The company develops drugs to treat high blood pressure and heart failure. Its research programs are based on the Brain Aminopeptidase A Inhibition (BAPAI), a real triple action innovative therapeutic platform. Quantum Genomics BAPAI products pipeline include QGC001 for the treatment of high blood pressure with monotherapy drug; and QGC011 for the treatment of hypertension through combination therapy in pre-clinical phase. Quantum Genomics offers QGC006 for the optimization of the treatment of hypertension with a monotherapy drug; and QGC101 for the prevention and treatment of heart failure. The company partners with biotech research entities, academic teams and pharmaceutical and bio-science companies to develop new drugs. QGS is headquartered in Paris, Ile-de-France, France.
Quantum Genomics SA Key Recent Developments
Mar 25,2021: Quantum Genomics Reports Full Year 2020 Operating and Financial Results
Feb 09,2021: Orient EuroPharma acquires Equity Stake in Quantum Genomics
Apr 07,2020: Quantum Genomics provides update on the impact of the COVID-19 health crisis on clinical research activities
Mar 26,2020: Quantum Genomics secured new financing, published its financial statements for fiscal year 2019 and provides 2019 highlights
This comprehensive SWOT profile of Quantum Genomics SA provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Quantum Genomics SA including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).
The profile contains critical company information including*,
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note*: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include,
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
Section 1 – About the Company
Quantum Genomics SA – Key Information
Quantum Genomics SA – Overview
Quantum Genomics SA – Key Employees
Quantum Genomics SA – Key Employee Biographies
Quantum Genomics SA – Key Operational Heads
Quantum Genomics SA – Major Products and Services
Quantum Genomics SA – History
Quantum Genomics SA – Company Statement
Quantum Genomics SA – Locations And Subsidiaries
Quantum Genomics SA
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Quantum Genomics SA – Business Description
Quantum Genomics SA – Corporate Strategy
Quantum Genomics SA – SWOT Analysis
SWOT Analysis – Overview
Quantum Genomics SA – Strengths
Quantum Genomics SA – Weaknesses
Quantum Genomics SA – Opportunities
Quantum Genomics SA – Threats
Quantum Genomics SA – Key Competitors
Section 3 – Company Financial Performance Charts
Quantum Genomics SA – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Appendix
Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
Note*: Some sections may be missing if data is unavailable for the company
List of Tables
Quantum Genomics SA, Key Information
Quantum Genomics SA, Key Ratios
Quantum Genomics SA, Share Data
Quantum Genomics SA, Major Products and Services
Quantum Genomics SA, History
Quantum Genomics SA, Key Employees
Quantum Genomics SA, Key Employee Biographies
Quantum Genomics SA, Key Operational Heads
Quantum Genomics SA, Other Locations
Quantum Genomics SA, Subsidiaries
Quantum Genomics SA, Key Competitors
Quantum Genomics SA, SWOT Analysis
Quantum Genomics SA, Ratios based on current share price
Quantum Genomics SA, Annual Ratios
Quantum Genomics SA, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios